Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Archives of Pathology & Laboratory Medicine|June 25, 2009
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancerAntonio C Wolff, M Elizabeth H Hammond, Jared N Schwartz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2006
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancerAntonio C Wolff, M Elizabeth H Hammond, Jared N Schwartz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 20, 2022
The Phase II MutHER Study of Neratinib Alone and in Combination with Fulvestrant in HER2-Mutated, Non-amplified Metastatic Breast CancerCynthia X Ma, Jingqin Luo, Rachel A Freedman, et al.
Future Oncology (London, England)|May 9, 2015
Personalization of loco-regional care for primary breast cancer patients (part 1)Masakazu Toi, Eric P Winer, John R Benson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 28, 2019
First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced CancersBranimir I Sikic, Nehal Lakhani, Amita Patnaik, et al.
Future Oncology (London, England)|May 9, 2015
Personalization of loco-regional care for primary breast cancer patients (part 2)Masakazu Toi, Eric P Winer, John R Benson, et al.
JAMA Oncology|January 22, 2021
Efficacy of Margetuximab vs Trastuzumab in Patients With Pretreated ERBB2-Positive Advanced Breast Cancer: A Phase 3 Randomized Clinical TrialHope S Rugo, Seock-Ah Im, Fatima Cardoso, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2022
Margetuximab Versus Trastuzumab in Patients With Previously Treated HER2-Positive Advanced Breast Cancer (SOPHIA): Final Overall Survival Results From a Randomized Phase 3 TrialHope S Rugo, Seock-Ah Im, Fatima Cardoso, et al.
Pageof 6